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Abstract
Background: The aim of this study was to evaluate short-term effects of a low-carbohydrate diet in overweight
and obese subjects with low HDL-C levels.
Methods: Overweight (BMI between 25-30 kg/m2) or obese (BMI over 30 kg/m2) subjects with low HDL-C levels
(men with HDL-C <1.03, women <1.29 mmol/l) were invited to the study. A 1400 kcal 75-gram carbohydrate
(CHO) diet was given to women and an 1800 kcal 100-gram CHO diet was given to men for four weeks. The
distribution of daily energy of the prescribed diet was 21-22% from CHO, 26-29% from protein and 49-53% from
fat. Subjects completed a three-day dietary intake record before each visit. Anthropometric indices, body fat
ratio, blood lipids, glucose and insulin were measured. Baseline and week-four results were compared with a
Wilcoxon signed ranks test.
Results: Twenty-five women and 18 men participated. Basal median LDL-C level of men was 3.11 and basal
median LDL-C level of women was 3.00 mmol/l. After four weeks of a low-carbohydrate diet, the median energy
intake decreased from 1901 to 1307 kcal/day, daily energy from carbohydrate from 55% to 33%, body weight from
87.7 to 83.0 kg and HDL-C increased from 0.83 to 0.96 mmol/l in men (p < 0.002, for all). After four weeks of a
low-carbohydrate diet, the median energy intake tended to decrease (from 1463 to 1243 kcal, p = 0.052), daily
energy from carbohydrate decreased from 53% to 30% (p < 0.001) and body weight decreased from 73.2 to 70.8
kg (p < 0.001) in women, but HDL-C did not significantly change (from 1.03 to 1.01 mmol/l, p = 0.165). There were
significant decreases in body mass index, waist circumference, body fat ratio, systolic blood pressure, total
cholesterol, triglyceride and insulin levels in all subjects.
Conclusions: HDL-C levels increased significantly with energy restriction, carbohydrate restriction and weight loss
in men. HDL-C levels didn’t change in women in whom there was no significant energy restriction but a
significant carbohydrate restriction and a relatively small but significant weight loss. Our results suggest that both
energy and carbohydrate restriction should be considered in overweight and obese subjects with low HDL-C
levels, especially when LDL-C levels are not elevated.
Background
A low high density lipoprotein cholesterol (HDL-C) level
is an independent risk factor for atherosclerotic cardio-
vascular disease (CVD) [1]. Even in subjects with a low
density lipoprotein cholesterol (LDL-C) level that is
below 60 mg/dl, either achieved with lipid lowering
agents or occurring spontaneously, HDL-C levels show
an inverse relationship with CVD risk and a U-shaped
relationship with all-cause mortality [2]. The increase in
HDL-C level has been found to have a strong indepen-
dent effect in reducing CVD risk after adjustment of
other lipid changes in patients who are on lipid lowering
therapy [3]. Although relatively effective LDL-C lowering
medical therapies are available, drugs that raise HDL-C
level as the principal pharmacodynamic effect do not
exist. Physical activity, cessation of smoking, weight loss,
moderate alcohol intake, a diet rich in omega-3 polyunsa-
turated fatty acids and a diet low in carbohydrates are
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HDL-C raising strategies [4]. The Mediterranean diet has
beneficial effects on CVD risk [5] and is effective in rais-
ing HDL-C levels [6]. A targeted lifestyle change program
improves CVD risk factors and the distribution of plasma
lipoprotein subclasses, especially small dense LDL-C
particles [7]. The United States National Cholesterol
Education Program Adult Treatment Panel III (NCEP)
recommends therapeutic lifestyle changes diet to reduce
the risk of CVD [1]. The distribution of daily energy
intake is 50-60% from carbohydrate, 15% from protein
and 25-35% from fat in the therapeutic lifestyle changes
diet. American Heart Association and World Health
Organization also recommend a low-fat diet [8,9]. In
view of the recent data on the benefits of low-carbohy-
drate diets, these official recommendations have been
challenged [10-12]. The primary objective of the thera-
peutic lifestyle changes diet is to reduce LDL-C levels to
prevent CVD, but low-fat diets decrease HDL-C levels
and increase triglycerides as well [13-18]. There are no
dietary intervention studies performed in subjects with
only low HDL-C levels. The aim of this study was to eval-
uate the effects of a low-carbohydrate diet in overweight
and obese subjects with low HDL-C levels.
Methods
Subjects were invited to the study from the Turkish
Heart Study database. Turkish Heart Study is an epide-
miological survey of CVD risk factors periodically per-
formed in Turkey. In 2005 and 2006, we reviewed our
2003 Turkish Heart Study data [19] and invited over-
weight [body mass index (BMI) ≥25 and <30 kg/m2]
and obese (BMI ≥30 kg/m2) subjects with a low HDL-C
level. NCEP HDL-C criterion [HDL-C <50 mg/dl
(1.29 mmol/l) for women and <40 mg/dl (1.03 mmol/l)
for men] was used to categorize subjects to low HDL-C
status [1]. The exclusion criteria were the presence of a
major medical illness like renal disease, liver disease,
cancer, diabetes and CVD and the use of lipid-lowering
drugs. A phone call was made to subjects for invitation
and to explain the study. Subjects who agreed to partici-
pate were instructed on how to record dietary intake
and were asked to come to our outpatient offices
between 7 am and 10 am after a 10-hour fast. At each
visit blood pressure, anthropometric indices and body
fat ratio were measured and a fasting blood sample was
obtained. The study was approved by the Ethics Com-
mittee of Kadir Has University, Faculty of Medicine. All
subjects signed written informed consent.
Clinical variables
Body weight and composition were measured with a
Tanita Body Composition Analyzer BC-418 MA (Tanita
Corporation, Tokyo, Japan). Bioimpedance analysis was
performed in the morning before breakfast and subjects
were instructed to void before the measurement. Body
weight was measured in kilograms to within 0.1 kg. Height
was measured to within 0.5 cm with a measuring stick.
BMI was calculated by dividing the weight in kilograms to
squared height in meters. Waist circumference was mea-
sured at the midpoint between lower margin of the rib
cage and superior iliac crest during mild expiration with a
non-elastic measuring tape. Waist circumference was mea-
sured to the nearest 0.5 cm. All measurements were taken
when subjects were on light clothing and after shoes were
taken off. Blood pressure was measured on the right arm
with an automated sphygmomanometer (Omron auto-
matic blood pressure monitor with IntelliSense®, Bannock-
burn, IL, USA) after fifteen minute of rest with the subject
in the sitting position. The mean of two recordings, five
minutes apart was recorded.
The metabolic syndrome was defined by the NCEP cri-
teria that were modified by the American Heart Associa-
tion and the United States National Heart Lung and Blood
Institute [1,20]. According to NCEP, metabolic syndrome
is diagnosed if three of the following five components
are abnormal: 1) waist circumference≥102 cm in men or
≥88 cm in women, 2) systolic blood pressure≥130 mmHg
or diastolic blood pressure≥85 mmHg, 3) serum triglycer-
ides≥150 mg/dl (1.69 mmol/l), 4) HDL-C <50 mg/dl
(1.29 mmol/l) for women and <40 mg/dl (1.03 mmol/l)
for men [1], 5) fasting plasma glucose≥100 mg/dl
(5.56 mmol/l) [20]. Subjects on drug therapy for hyperten-
sion, high blood glucose or abnormal lipid levels are also
assigned to abnormal component status [20].
Laboratory variables
A cobas 6000 multichannel analyzer (Hitachi High
Technologies Corporation, Tokyo, Japan) and commer-
cial kits (Roche Diagnostics, Mannheim, Germany) were
used for measurement of cholesterol, HDL-C, triglycer-
ides and glucose. Cholesterol (kit: CHOL2) and trigly-
cerides (kit: TRIGL) were measured with an enzymatic
colorimetric method. A homogeneous enzymatic colori-
metric test was used for direct measurement of HDL-C
(kit: HDLC3). LDL cholesterol (LDL-C) was calculated
by the Friedewald formula. Glucose (kit: GLUC3) was
measured by hexokinase method. Fasting insulin levels
were measured with an electrochemiluminescence
immunoassay (kit: Insulin) in a cobas e 411 analyzer
(Hitachi High Technologies Corporation, Tokyo, Japan).
Insulin resistance was estimated by Homeostasis Model
Assessment (HOMA) equation. HOMA equals fasting
serum insulin (μU/ml) times fasting plasma glucose
(mmol/l) divided by 22.5 [21].
Dietary intervention
The participants were free-living and were instructed
not to alter their physical activity level during the study.
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Subjects visited Medical Nutrition Center three times:
basal, at two weeks and at four weeks. The results of
baseline and week-four visits are reported here. Subjects
were asked to complete a three-day food intake record
prior to each visit. The daily energy intake and the diet-
ary composition were calculated from subjects’ dietary
history records by pen and paper [22]. Sample menus
that were given to subjects were shown in the additional
file 1. Women were instructed to follow a 1400 kcal
75-gram carbohydrate diet for four weeks. 21% of daily
energy was from carbohydrate, 26% from protein and
53% from fat in the diet that was recommended to
women. The analysis of the sample menu with BEBIS
nutritional analysis software program (developed by
Stuttgart-Hohenheim University, Stuttgart, Germany)
showed that the prescribed diet for women included
52% polysaccharides, 17% disaccharides and 31% mono-
saccharides and 21 grams of fiber daily. The prescribed
simple sugar intake constituted approximately 7% of the
total energy intake. The distribution of fatty acids was
as follows: 33% saturated, 17% polyunsaturated and 50%
monounsaturated fatty acids. Ingested proteins were
mainly of animal origin and vegetable proteins consti-
tuted approximately 22% of daily protein intake in the
1400 kcal 75-gram carbohydrate diet that was prescribed
to women. Men were instructed to follow an 1800 kcal
100-gram carbohydrate diet for four weeks. 22% of daily
energy was from carbohydrate, 29% from protein and
49% from fat in the diet that was recommended to men.
The analysis of the sample menu with BEBIS nutritional
analysis software program showed that the prescribed
diet for men included 59% polysaccharides, 17% disac-
charides and 24% monosaccharides and 27 grams of
fiber daily. The prescribed simple sugar intake consti-
tuted approximately 5% of the total energy intake. The
distribution of fatty acids was as follows: 32% saturated,
20% polyunsaturated and 48% monounsaturated fatty
acids. Ingested proteins were mainly of animal origin
and vegetable proteins constituted approximately 19% of
daily protein intake in the 1800 kcal 100-gram carbohy-
drate diet that was prescribed to men. Meat, chicken or
fish consumption was recommended once or twice per
day to all subjects (additional file 1). As following a low-
carbohydrate diet is expensive, subjects were given food
products like salami, sausages, nuts and cheese to pre-
vent noncompliance. Subjects were counseled to select
from different food items at each visit. None of the par-
ticipants consumed pork because pork is religiously for-
bidden in Islam and is not available on the Turkish
market.
Statistical methods
Before- and after-diet clinical and laboratory variables
were compared. There was no control group. Last
observation was carried forward for subjects who did
not come to their last scheduled visit and for data that
the investigators failed to collect or record. Results at
week-2 were carried forward to week-4 for subjects who
attended only to the baseline and week-2 visits. Subjects
who attended to only baseline visit were excluded from
data analysis. Categorical variables were presented as
frequencies and percentages. Baseline social characteris-
tics of men and women were compared with a c2 test.
When there were any expected frequencies less than
five, the rest of the categories were collapsed. Fisher’s
exact test was employed instead of c2 test when the
expected frequencies were still less than five after col-
lapsing the rest of the categories. Before- and after-diet
results for continuous variables were presented as med-
ian, 25th and 75th percentile and were compared with a
Wilcoxon signed ranks test. Before- and after-diet cate-
gorical variables were compared with a McNemar’s test.
The correlations between the change in energy intake,
the change in carbohydrate intake or the change in insu-
lin sensitivity and the change in outcome variables were
found by calculating Pearson product-moment correla-
tion coefficient or Spearman’s rank correlation coeffi-
cient, as appropriate. The relation between starting
weight and weight loss was estimated by Spearman’s
rank correlation coefficient. The Statistical Package for
Social Sciences software, version 17.0 (SPSS Inc.,
Chicago, IL, USA) was used for statistical analyses.
Results
There are 43 subjects, 18 men and 25 women in this
study. Initially 50 subjects, 22 men and 28 women
agreed to participate. Seven subjects (four men and
three women) came only to the basal screening and did
not follow the diet at all. Therefore, they were excluded
from the analysis. Three subjects (one man and two
women) came only to the baseline and week-2 visits and
their results were carried forward to week-4. Eighty per-
cent of (40 out of 50) subjects were compliant with the
prescribed diet and attended to all three visits. Six men
and six women were married to each other. The mean
age of men was 38 and standard deviation (SD) was
seven years. The mean age of women was 39 and SD
was seven years. Social characteristics of the subjects
were given in Table 1. Men were more educated than
women. There were no differences in smoking, alcohol
drinking and physical activity habits between men and
women. Twelve men (67%) were overweight and six
men (33%) were obese. Ten women (40%) were over-
weight and 15 women (60%) were obese (c2 = 2.978,
p = 0.084 between men and women). Energy content
and macronutrient composition before and after the diet
were shown in Table 2. The median of men’s baseline
energy intake was 1901 kcal and was slightly higher
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than the energy value of the prescribed diet (1800 kcal).
Compared to baseline, men achieved around 600 kcal
energy deficit with the low-carbohydrate diet. There was
a significant reduction in percent energy from carbohy-
drate and a significant increase in percent energy from
protein and fat in men. Men’s individual data for daily
energy intake was illustrated in Figure 1. Men’s indivi-
dual data for daily carbohydrate intake was illustrated in
Figure 2. Eighty-nine percent of men (16/18) had an
energy intake below the target level of 1800 kcal at the
end of the study. Only 39% of men (7/18) were able to
achieve the target carbohydrate intake of 100 grams or
less per day. The median of women’s baseline energy
intake was 1463 kcal and was close to the energy value
of the prescribed diet (1400 kcal). Women had an insig-
nificant 220 kcal energy deficit with the prescribed low-
carbohydrate diet. There was a significant reduction in
percent energy from carbohydrate and a significant
increase in percent energy from fat in women. Percent
energy from protein did not change significantly before
and after the diet in women. Women’s individual data
for daily energy intake was illustrated in Figure 1.
Women’s individual data for daily carbohydrate intake
was illustrated in Figure 2. Eighty-three percent of
women (19/23) had an energy intake below the target
level of 1400 kcal at the end of the study. Only 22% of
women (5/23) were able to achieve the target carbohy-
drate intake of 75 grams or less per day.
As shown in Table 3 and Table 4, after four weeks of
an energy-restricted low-carbohydrate diet, all subjects
had significant reductions in body weight, BMI, waist
circumference, body fat ratio, systolic blood pressure,
and total cholesterol, triglyceride and insulin levels, TC/
HDL-C ratio and HOMA value compared to baseline.
There was a significant increase in median HDL-C levels
in men, but not in women. The increase in HDL-C level
Table 1 Social characteristics and life-style habits of
subjects
Parameter Men
(n = 18)
Women
(n = 25)
p value
Education
Less than 6 years of education 39% (7) 72% (18) 0.030
Between 6 and 11 years of education* 22% (4) 20% (5) 1.000
More than 12 years of education* 39% (7) 8% (2) 0.023
Smoking
Never-smoker 44% (8) 52% (13) 0.625
Ex-smoker* 22% (4) 4% (1) 0.144
Current-smoker 33% (6) 44% (11) 0.480
Alcohol drinking
Non-drinker* 72% (13) 84% (21) 0.455
Drinker* 28% (5) 16% (4) 0.455
Exercise
None to less than 1 hour/week 67% (12) 64% (16) 0.856
Between 1-4 hour/week* 22% (4) 20% (5) 1.000
More than 4 hour/week* 11% (2) 16% (4) 1.000
Non-drinker: subject does not consume any alcoholic beverage at all Drinker:
consumes less than one glass of alcoholic beverage or more per week
Percentage and frequency are given and c2 test is used to compare groups in
unmarked rows *percentage and frequency are given and Fisher’s exact test is
used to compare groups
Table 2 Dietary energy and composition before and after four weeks of an energy-restricted low-carbohydrate diet in
overweight or obese subjects with low HDL-C levels
Before-diet* After-diet* p value†
Men (n = 18)‡
Energy intake (kcal/day) 1901 (1598, 2479) 1307 (1000, 1619) 0.001
CHO intake (%) 55 (48, 61) 33 (28, 42) <0.001
CHO intake (gram/day) 271 (214, 312) 111 (93, 126) <0.001
Protein intake (%) 14 (13, 16) 22 (19, 26) <0.001
Protein intake (gram/day) 63 (54, 99) 74 (54, 85) 0.619
Fat intake (%) 32 (27, 33) 45 (37, 47) 0.001
Fat intake (gram/day) 71 (51, 85) 65 (44, 80) 0.407
Women (n = 23)§
Energy intake (kcal/day) 1463 (1132, 1852) 1243 (1012, 1313) 0.052
CHO intake (%) 53 (45, 58) 30 (28, 39) <0.001
CHO intake (gram/day) 192 (125, 220) 92 (80, 114) <0.001
Protein intake (%) 14 (12, 16) 18 (16, 21) 0.109
Protein intake (gram/day) 50 (33, 63) 53 (41, 69) 0.627
Fat intake (%) 31 (26, 36) 48 (43, 55) <0.001
Fat intake (gram/day) 47 (41, 62) 68 (45, 79) 0.005
CHO: carbohydrate *median (25th, 75th percentile) are given in the column †before- and after-diet results are compared with a Wilcoxon signed ranks test ‡men
were prescribed an 1800 kcal 100-gram carbohydrate diet for four weeks §women were prescribed a 1400 kcal 75-gram carbohydrate diet for four weeks Daily
macronutrient intake is given as percent energy from macronutrient in upper rows and as amount of macronutrient in grams in lower rows in lines illustrating
macronutrient intake.
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Figure 1 Individual data of daily energy intake before and after low-carbohydrate diet. Energy intake from food records before and after
four weeks of an 1800 kcal 100-gram carbohydrate diet in overweight or obese men with low HDL-C levels and before and after four weeks of
a 1400 kcal 75-gram carbohydrate diet in overweight or obese women with low HDL-C levels.
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Figure 2 Individual data of daily carbohydrate intake before and after low-carbohydrate diet. Carbohydrate intake from food records
before and after four weeks of an 1800 kcal 100-gram carbohydrate diet in overweight or obese men with low HDL-C levels and before and
after four weeks of a 1400 kcal 75-gram carbohydrate diet in overweight or obese women with low HDL-C levels.
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was accompanied by a ~600 kcal daily energy deficit and
a -4.7 kg difference in median body weight in men.
After four weeks of a low-carbohydrate diet, there was
no significant change in HDL-C levels in women. This
was accompanied by an insignificant 220 kcal daily
energy deficit but a significant -2.4 kg difference in
median body weight in women. The frequency of the
metabolic syndrome and abnormal HDL-C component
significantly improved only in men and the frequency of
the metabolic syndrome tended to improve in women
(Table 5). The scatter plot of the change in daily energy
intake versus the change in HDL-C level was presented
in Figure 3. The scatter plot of the change in daily car-
bohydrate intake versus the change in HDL-C level was
presented in Figure 4. The correlation coefficients
between the change in energy intake, the change in car-
bohydrate intake or the change in insulin sensitivity and
the change in outcome variables were weak (Table 6).
The change in daily energy intake was significantly cor-
related with the change in triglycerides in men. The
change in daily carbohydrate intake was significantly
correlated with the change in body weight, total choles-
terol/HDL-C ratio and triglycerides in the whole
group. The change in daily carbohydrate intake was
Table 3 Anthropometric indices, bioimpedance analysis,
blood pressure and laboratory variables before and after
four weeks of an 1800 kcal 100-gram carbohydrate diet
in overweight or obese men with low HDL-C levels
n* Before-diet† After-diet† p value‡
Body weight (kg) 18 87.7 (82.9, 96.8) 83.0 (80.5, 90.3) <0.001
BMI (kg/m2) 18 29.1 (28.2, 30.6) 27.9 (26.8, 28.9) <0.001
WC (cm) 16 104.8 (101.0, 108.1) 99.3 (95.4, 104.1) <0.001
Body fat ratio (%) 17 25.4 (23.0, 27.7) 23.4 (20.2, 26.4) 0.010
Fat mass (kg) 17 22.0 (19.8, 24.9) 20.8 (16.6, 22.6) <0.001
SBP (mmHg) 17 130 (123, 140) 124 (119, 134) 0.003
DBP (mmHg) 17 76 (73, 91) 80 (71, 84) 0.297
TC (mmol/l) 18 4.34 (4.13, 5.29) 4.20 (3.76, 4.95) 0.029
HDL-C (mmol/l) 18 0.83 (0.74, 0.88) 0.96 (0.82, 1.03) <0.001
TC/HDL-C 18 5.56 (4.50, 7.28) 4.47 (3.91, 5.20) <0.001
LDL-C (mmol/l) 18 3.11 (2.54, 3.76) 2.80 (2.32, 3.56) 0.058
TG (mmol/l) 18 1.23 (0.85, 1.85) 0.95 (0.63, 1.27) 0.004
Glucose (mmol/l) 18 4.94 (4.64, 5.13) 4.88 (4.66, 5.12) 0.983
Insulin (pmol/l) 17 80.3 (59.3, 98.3) 61.2 (45.5, 81.4) 0.005
HOMA 17 2.47 (1.74, 3.32) 1.89 (1.31, 2.63) 0.003
BMI: body mass index, WC: waist circumference, SBP: systolic blood pressure,
DBP: diastolic blood pressure, TC: total cholesterol, HDL-C: high density
lipoprotein cholesterol, LDL-C: low density lipoprotein cholesterol,
TG: triglycerides, HOMA: homeostasis model assessment of insulin resistance
*some data are missing for some of the variables †median (25th, 75th
percentile) are given in the column ‡before- and after-diet results are
compared with a Wilcoxon signed ranks test
Table 4 Anthropometric indices, bioimpedance analysis,
blood pressure and laboratory variables before and after
four weeks of a 1400 kcal 75-gram carbohydrate diet in
overweight or obese women with low HDL-C levels
n* Before-diet† After-diet† p value‡
Body weight (kg) 25 73.2 (68.5, 81.7) 70.8 (65.5, 79.1) <0.001
BMI (kg/m2) 25 30.4 (28.0, 32.9) 29.5 (27.2, 31.4) <0.001
WC (cm) 25 95.0 (87.5, 99.0) 92.0 (86.0, 96.5) 0.002
Body fat ratio (%) 24 38.0 (34.6, 39.7) 34.6 (32.7, 39.6) <0.001
Fat mass (kg) 24 27.7 (23.4, 31.7) 24.3 (22.1, 29.9) <0.001
SBP (mmHg) 25 123 (115, 132) 112 (107, 124) 0.005
DBP (mmHg) 25 82 (74, 91) 79 (76, 84) 0.253
TC (mmol/l) 25 4.50 (3.84, 5.25) 3.93 (3.56, 4.42) <0.001
HDL-C (mmol/l) 25 1.03 (0.94, 1.09) 1.01 (0.89, 1.14) 0.165
TC/HDL-C 25 4.34 (3.73, 5.48) 3.81 (3.35, 4.30) <0.001
LDL-C (mmol/l) 25 3.00 (2.37, 3.59) 2.46 (2.13, 2.93) <0.001
TG (mmol/l) 25 1.12 (0.89, 1.58) 0.82 (0.73, 1.12) 0.011
Glucose (mmol/l) 25 5.11 (4.91, 5.41) 5.11 (4.83, 5.55) 0.742
Insulin (pmol/l) 23 61.0 (46.6, 96.4) 56.0 (38.0, 92.6) 0.005
HOMA 23 2.01 (1.44, 2.92) 1.71 (1.24, 2.74) 0.006
BMI: body mass index, WC: waist circumference, SBP: systolic blood pressure,
DBP: diastolic blood pressure, TC: total cholesterol, HDL-C: high density
lipoprotein cholesterol, LDL-C: low density lipoprotein cholesterol, TG:
triglycerides, HOMA: homeostasis model assessment of insulin resistance
*some data are missing for some of the variables †median (25th, 75th
percentile) are given in the column ‡before- and after-diet results are
compared with a Wilcoxon signed ranks test
Table 5 The frequency of the metabolic syndrome and its
components before and after four weeks of an energy-
restricted low-carbohydrate diet in overweight or obese
subjects with low HDL-C levels
n* Before-
diet†
After-
diet†
p
value‡
Men§
Metabolic Syndrome∥ 16 50% 17% 0.031
Abnormal waist circumference
criterion
16 56% 33% 0.125
Abnormal glucose criterion 18 11% 6% 1.000
Abnormal triglyceride criterion 18 33% 6% 0.063
Abnormal HDL-C criterion 18 100% 61% 0.016
Abnormal blood pressure
criterion
17 53% 33% 0.250
Women¶
Metabolic Syndrome∥ 25 48% 24% 0.070
Abnormal waist circumference
criterion
25 76% 60% 0.125
Abnormal glucose criterion 25 16% 28% 0.250
Abnormal triglyceride criterion 25 16% 4% 0.250
Abnormal HDL-C criterion 25 100% 88% 0.250
Abnormal blood pressure
criterion
25 40% 24% 0.219
*some data are missing for some of the variables †percentage is given in the
column ‡before- and after-diet frequencies are compared with a McNemar’s
test §men were prescribed an 1800 kcal 100-gram (22% of daily energy from)
carbohydrate diet ∥the metabolic syndrome and its components are defined
according to modified United States National Cholesterol Education Program
Adult Treatment Panel III criteria [1,20] ¶women were prescribed a 1400 kcal
75-gram (21% of daily energy from) carbohydrate diet
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significantly correlated with the change in body weight,
BMI, total cholesterol/HDL-C ratio and triglycerides in
men and with the change in diastolic blood pressure,
insulin levels and HOMA in women. There were more
instances in which the change in carbohydrate intake
was significantly correlated with outcome variables than
the change in energy intake (Table 6). The correlation
between baseline weight and weight loss was not signifi-
cant, Spearman’s rho= -0.186, p = 0.460 in men and
Spearman’s rho = 0.014, p = 0.948 in women. The start-
ing weight and final weight were highly correlated
(Spearman’s rho = 0.983, p < 0.001 for men and Spear-
man’s rho = 0.987, p < 0.001 for women). The relation
between the baseline weight and the final weight was
shown in Figure 5. The scatter plot of the change in
daily energy intake versus weight loss was presented in
Figure 6. The scatter plot of the change in daily energy
intake from carbohydrate versus weight loss was pre-
sented in Figure 7. The scatter plot of the change in
daily carbohydrate intake versus weight loss was pre-
sented in Figure 8.
Discussion
Beneficial effects of low-carbohydrate diets have been
observed before. These studies were on normal weight
normolipidemic subjects [17,18], overweight or obese
subjects [13-16,23-25], subjects with hypertension
[14,26], metabolic syndrome [14,16,26,27], hyperlipide-
mia [13,15] or diabetes [16,27,28]. Our study evaluates
the effects of a low-carbohydrate diet in subjects with
low HDL-C levels. Compared to North American or
European populations, Turks have low levels of total
cholesterol and HDL-C and relative roles of the meta-
bolic syndrome and atherogenic dyslipidemia are more
pronounced [29]. The mean and SD of HDL-C levels of
Turkish men are 37 and 12 mg/dl, respectively. The
mean and SD of HDL-C levels of Turkish women are
45 and 13 mg/dl, respectively [30]. Molecular genetic
studies showed that single nucleotide polymorphisms in
hepatic lipase, cholesterol ester transfer protein and
ATP binding cassette transporter A1 genes are asso-
ciated with plasma HDL-C levels in the Turkish popula-
tion [31-34]. A previous study showed that 61% of adult
Figure 3 Scatter plot of the change in daily energy intake and the change in HDL-C after four weeks of low-carbohydrate diet in
overweight or obese subjects with low HDL-C levels. A line of best fit with 95% confidence intervals is shown. Men were prescribed an
1800 kcal 100-gram carbohydrate diet for four weeks and women were prescribed a 1400 kcal 75-gram carbohydrate diet for four weeks.
Change in HDL-C: HDL-C level at week-4 minus HDL-C level at baseline Change in daily energy intake: energy intake at week-4 minus energy
intake at baseline.
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nondiabetic Turkish population had low HDL-C levels
(<40 mg/dl for men and <50 mg/dl for women) [35].
Therefore, we think that the effects of dietary therapy
should be investigated in subjects with low HDL-C
levels, especially in a population with a high prevalence
of low HDL-C levels. Al-Sarraj and coworkers showed
that a carbohydrate-restricted diet improves insulin
resistance and all features of the metabolic syndrome
except for the low HDL-C component in Emirati adults
[36]. The authors commented that genetic predisposi-
tion to low HDL-C might explain the lack of effect of
the low-carbohydrate diet on HDL-C levels [36]. Simi-
larly, genetic factors have been found to be associated
with low HDL-C levels in the Turkish population
[31-34]. In contrast to the above-mentioned study in
Emirati adults, a low-carbohydrate diet with energy
restriction raised HDL-C levels in men in our study. As
there are discrepant results among dietary intervention
studies, further studies are needed in subjects with low
HDL-C levels.
It has been reported that carbohydrate intake is
related to HDL-C levels and every 100 gram/day
increment of carbohydrate intake is associated with a
5.8 mg/dl (0.15 mmol/L) decrease in HDL-C levels after
adjustment of confounders in a multivariate nutrient
residual model [37]. A low-carbohydrate diet is effective
in improving glycemic control and reducing hemoglobi-
nA1c levels in subjects with diabetes mellitus [28]. Volek
and Feinman proposed that the metabolic syndrome
should be defined as an entity that favorably responds
to carbohydrate restriction because a low-carbohydrate
diet effectively targets each component of the metabolic
syndrome: central obesity, low HDL-C, high triglycer-
ides, high blood pressure and high blood glucose
[10,11]. The mechanism of improvement is thought to
be secondary to reduction of insulin resistance. Volek
et al. stressed that dietary carbohydrate intake is a key
element in disposal of excess dietary fat intake, directly
or indirectly through the secretion of insulin [38]. Diet-
ary carbohydrate modulates lipolysis, de novo lipogenesis
and effects the interaction between dietary fat intake
and plasma saturated fatty acid levels. Volek et al.
showed that when carbohydrate intake was low and
consequently plasma glucose and insulin levels were
Figure 4 Scatter plot of the change in daily carbohydrate intake and the change in HDL-C after four weeks of low-carbohydrate diet
in overweight or obese subjects with low HDL-C levels. A line of best fit with 95% confidence intervals is shown. Men were prescribed an
1800 kcal 100-gram carbohydrate diet for four weeks and women were prescribed a 1400 kcal 75-gram carbohydrate diet for four weeks.
Change in HDL-C: HDL-C level at week-4 minus HDL-C level at baseline Change in daily carbohydrate intake: the amount of carbohydrate intake
at week-4 minus the amount of carbohydrate intake at baseline.
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lower, a higher saturated fat intake would cause a reduc-
tion in relative proportions of circulating saturated fatty
acids in triglyceride and cholesterol ester fractions [39].
In addition to improving classical cardiovascular risk
factors, compared to a low-fat diet, a low-carbohydrate
diet favorably effects nonclassical cardiovascular risk fac-
tors like apo B, apo A-I, apo B/apo A-I ratio, LDL parti-
cle size and distribution [39], postprandial lipemia and
postprandial vascular endothelial function as assessed by
flow-mediated dilatation [40]. Carbohydrate restriction
also exerts an anti-inflammatory effect with a decrease
in proinflammatory cytokine tumor necrosis factor-a,
the chemokines interleukin-8 and monocyte chemotactic
protein-1, the adhesion molecules E-selectin and intra-
cellular adhesion molecule-1 and antifibrinolytic sub-
stance plasminogen-activator inhibitor-1 [41]. In
summary, a large body of evidence indicates that abnor-
mal fatty acid status and inflammatory state that are
characteristics of the metabolic syndrome are better
improved by a low-carbohydrate diet than a low-fat diet
[38-41]. Low-carbohydrate diets have different favorable
effects on CVD risk factors than low-fat diets [15,16].
Meckling and coworkers proposed that a low-fat diet
should be initiated when reduction of blood cholesterol
is the primary goal and a low-carbohydrate diet should
be initiated when reduction of insulin resistance is the
primary goal [13]. In view of our findings, we suggest
that an energy-restricted low-carbohydrate diet should
be initiated when an increase in HDL-C level is the pri-
mary goal.
Limitations of the study
Even if some low-carbohydrate food items were provided
free of charge, the vast majority of subjects could not
achieve the target carbohydrate intake in our study. In
contrast, most subjects reached their goal in caloric
restriction. As low-carbohydrate food items are expensive,
Table 6 The correlation coefficients between the change
in daily energy intake, the change in daily carbohydrate
intake or the change in insulin sensitivity and outcome
variables before and after four weeks of low-
carbohydrate diet in overweight or obese subjects with
low HDL-C levels
Δ Energy intake Δ CHO intake Δ HOMA
All subjects†
Δ body weight 0.286 0.321* -0.085
Δ BMI 0.121 0.183 -0.133
Δ WC 0.132 0.142 -0.144
Δ body fat ratio -0.182 -0.189 0.168
Δ fat mass -0.120 0.103 0.131
Δ SBP 0.082 0.126 -0.060
Δ DBP 0.307 0.285 0.139
Δ TC -0.084 -0.033 -0.030
Δ HDL-C -0.172 -0.266 -0.059
Δ TC/HDL-C 0.134 0.319* 0.033
Δ LDL-C -0.218 -0.214 -0.051
Δ TG 0.303 0.427** 0.059
Δ Glucose -0.113 -0.84 0.589**
Δ Insulin 0.263 0.220 0.981**
Δ HOMA 0.213 0.162 1
Men‡§
Δ body weight 0.386 0.493* -0.530*
Δ BMI 0.352 0.482* -0.569*
Δ WC 0.296 0.385 -0.300
Δ body fat ratio 0.088 0.211 0.414
Δ fat mass 0.115 0.303 0.072
Δ SBP 0.400 0.475 0.039
Δ DBP 0.352 0.126 0.196
Δ TC 0.185 0.375 0.012
Δ HDL-C -0.349 -0.421 0.093
Δ TC/HDL-C 0.232 0.552* -0.130
Δ LDL-C -0.098 0.001 0.002
Δ TG 0.601** 0.677** 0.118
Δ Glucose -0.209 -0.319 0.384
Δ Insulin -0.034 -0.189 0.966**
Δ HOMA -0.007 -0.174 1
Women‡∥
Δ body weight -0.123 0.001 0.160
Δ BMI -0.149 -0.050 0.148
Δ WC -0.140 -0.146 -0.186
Δ body fat ratio -0.149 -0.179 0.115
Δ fat mass -0.167 -0.131 0.180
Δ SBP 0.060 0.200 0.064
Δ DBP 0.211 0.442* 0.085
Δ TC -0.038 -0.038 0.067
Δ HDL-C 0.057 -0.063 -0.036
Δ TC/HDL-C -0.075 0.036 0.081
Δ LDL-C -0.080 -0.137 0.083
Δ TG 0.029 0.260 0.106
Δ Glucose -0.082 0.072 0.614**
Δ Insulin 0.394 0.449* 0.975**
Table 6 The correlation coefficients between the change
in daily energy intake, the change in daily carbohydrate
intake or the change in insulin sensitivity and outcome
variables before and after four weeks of low-carbohy-
drate diet in overweight or obese subjects with low HDL-
C levels (Continued)
Δ HOMA 0.390 0.435* 1
Δ: difference between the value at week-4 and the value at baseline, energy
intake: daily energy intake obtained from food records, carbohydrate intake:
daily amount of carbohydrate intake in grams obtained from food records,
HOMA: homeostasis model assessment of insulin resistance, BMI: body mass
index, WC: waist circumference, SBP: systolic blood pressure, DBP: diastolic
blood pressure, TC: total cholesterol, HDL-C: high density lipoprotein
cholesterol, LDL-C: low density lipoprotein cholesterol, TG: triglycerides, *p <
0.05 †Pearson product-moment correlation coefficient ‡Spearman’s rank
correlation coefficient §men were prescribed an 1800 kcal 100-gram (22% of
daily energy from) carbohydrate diet ∥women were prescribed a 1400 kcal 75-
gram (21% of daily energy from) carbohydrate diet
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Figure 5 Scatter plot of the baseline weight and the final weight after four weeks of low-carbohydrate diet in overweight or obese
subjects with low HDL-C levels. A line of best fit with 95% confidence intervals is shown. Men were prescribed an 1800 kcal 100-gram
carbohydrate diet for four weeks and women were prescribed a 1400 kcal 75-gram carbohydrate diet for four weeks.
Figure 6 Scatter plot of the change in daily energy intake and the change in body weight after four weeks of low-carbohydrate diet
in overweight or obese subjects with low HDL-C levels. A line of best fit with 95% confidence intervals is shown. Men were prescribed an
1800 kcal 100-gram carbohydrate diet for four weeks and women were prescribed a 1400 kcal 75-gram carbohydrate diet for four weeks.
Change in body weight: weight at week-4 minus weight at baseline Change in daily energy intake: daily energy intake at week-4 minus daily
energy intake at baseline.
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Figure 7 Scatter plot of the change in daily energy intake from carbohydrate and the change in body weight after four weeks of low-
carbohydrate diet in overweight or obese subjects with low HDL-C levels. A line of best fit with 95% confidence intervals is shown. Men
were prescribed an 1800 kcal 100-gram carbohydrate diet for four weeks and women were prescribed a 1400 kcal 75-gram carbohydrate diet for
four weeks. Change in body weight: weight at week-4 minus weight at baseline Change in daily energy from carbohydrate: daily energy from
carbohydrate at week-4 minus daily energy from carbohydrate at baseline.
Figure 8 Scatter plot of the change in daily carbohydrate intake and the change body weight after four weeks of low-carbohydrate
diet in overweight or obese subjects with low HDL-C levels. A line of best fit with 95% confidence intervals is shown. Men were prescribed
an 1800 kcal 100-gram carbohydrate diet for four weeks and women were prescribed a 1400 kcal 75-gram carbohydrate diet for four weeks.
Change in body weight: weight at week-4 minus weight at baseline Change in daily carbohydrate intake: the amount of carbohydrate intake at
week-4 minus the amount of carbohydrate intake at baseline.
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it may be difficult to follow a low-carbohydrate diet for the
long-term in a developing country, like Turkey. Another
limitation is that subjects were invited from a previous epi-
demiological study, not from the general population. The
beneficial outcomes observed in this study were obtained
with both energy and carbohydrate restriction. The results
of this study should be viewed as pilot data that warrant
further research. A long-term study with a control group
is needed to validate our results. Studies that prescribe
carbohydrate restriction with ad libitum energy intake
show an increase in HDL-C levels with the dietary inter-
vention [15,42-46], but there are few studies that show no
significant change in HDL-C levels with ad libitum low-
carbohydrate diets [16,27]. Studies that restricted both car-
bohydrate and energy intake showed a variable response in
HDL-C levels as well. Recent selected dietary intervention
studies that were published after 2002 and restricted car-
bohydrates to less than 40% of daily energy intake are
summarized in Table 7. Male to female ratio, duration, the
degree of energy and carbohydrate restriction, dietary
composition and the amount of weight loss are highly
variable in these studies. A consistent effect of a low-car-
bohydrate diet is a reduction of triglyceride levels. As seen
in Table 7, studies of low-carbohydrate diets in which sub-
jects lost greater amount of weight are consistently asso-
ciated with an elevation of HDL-C levels whereas studies
with smaller weight reduction are mostly associated with
no significant change in HDL-C levels. Except for our
study, none of the studies in Table 7 enrolled subjects
only with low HDL-C levels. Frisch and coworkers showed
no effect of a low-carbohydrate diet on HDL-C levels,
although carbohydrate restriction was only 40% of daily
energy intake in that study [12]. As seen in Table 7, only
few studies showed an elevation of LDL-C levels with low-
carbohydrate diets. We also did not observe an elevation
of LDL-C level with a low-carbohydrate diet in our study.
Carbohydrate restriction causes elevations in HDL-C
levels from increased reverse cholesterol transport. The
increase in HDL-C levels from carbohydrate restriction is
characterized by an increase in HDL particle size but not
quantity and an increase in lecithin:cholesterol acyltrans-
ferase activity with no change in cholesterol ester transfer
protein activity [47].
Conclusions
A short term energy-restricted low-carbohydrate diet
causes weight loss, fat loss, a decrease in total choles-
terol and triglyceride levels and an improvement in
insulin resistance in overweight and obese subjects with
low HDL-C levels. HDL-C levels increased significantly
with energy restriction, carbohydrate restriction and
weight loss in men. HDL-C levels did not change in
women in whom there was no significant energy restric-
tion but a significant carbohydrate restriction and a rela-
tively small but significant amount of weight loss.
Differences in gender, baseline characteristics of subjects
Table 7 Results from recent selected studies* that evaluated the effects of low-carbohydrate diets
Author Year n Basal BMI (kg/
m2)
Duration
(week)
Δ Energy (kcal/
day)
Dietary
composition
Δ weight
(kg)
HDL-
C
TG LDL-
C
Reference
Sharman 2002 12 m BMI<25 6 None 8/30/61 -2.2 ↔ ↓ ↔ [18]
Volek 2003 10 w BMI<25 4 None 10/29/60 -1.8 ↑ ↓ ↑ [17]
Volek 2004 13 w BMI≥25 4 -643 9/28/63 -3.0 ↔ ↔ ↔ [25]
Sharman 2004 15 m BMI≥25 6 -738 8/28/63 -6.1 ↔ ↓ ↔ [24]
Meckling
2004
5 m/10
w
BMI≥25 10 -763 16/26/56 -7.0 ↑ ↓ ↔ [13]
Noakes 2006 4 m/20
w
BMI>28 12 -615 25/30/50 -8.0 ↑ ↓ ↑ [48]
Westman
2008†
7 m/14
w
BMI>27 24 -578 13/28/59 -11.1 ↑ ↓ ↔ [28]
Brinkworth
2009
11 m/24
w
Abd obesity 52 -500 4/35/61 -14.5 ↑ ↓ ↑ [49]
Jenkins 2009‡ 10 m/15
w
BMI>27 4 -328 28/30/43 -3.9 ↔ ↓ ↓ [50]
Volek 2009 10 m/10
w
BMI>25 12 -847 13/28/59 -10.1 ↑ ↓ ↔ [39]
Can 2010 18 m BMI≥25 4 -600 33/22/45 -3.7 ↑ ↓ ↔ T
Can 2010 25 w BMI≥25 4 -220 30/18/48 -1.1 ↔ ↓ ↓ T
BMI: body mass index, Δ Energy: difference between end-study and baseline mean or median daily energy intake, Dietary composition: percentage of daily
energy from carbohydrate/protein/fat, Δ weight: difference between mean or median end-study and baseline weight, HDL-C: high density lipoprotein cholesterol,
TG: triglycerides, LDL-C: low density lipoprotein cholesterol, m: men, w: women, Abd obesity: abdominal obesity, T: this study. *selected studies published after
2002 and restricted carbohydrate intake to less than 40% of daily energy intake are included in the table. A summary of studies published prior to 2004 can be
found in the review by Volek and Feinman [10]. Studies of low-carbohydrate diets based on ad libitum energy intake, glycemic index or glycemic load are
excluded from the table. †only subjects with diabetes mellitus were enrolled into the study ‡protein and fat are from plant origin in the study
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and the dietary intervention may account for divergent
outcomes in HDL-C levels between men and women.
The results of this study suggest that both energy and
carbohydrate restriction should be considered in over-
weight and obese subjects with low HDL-C levels, espe-
cially when LDL-C levels are not elevated.
Additional material
Additional file 1: Sample menus. Sample menus for an 1800 kcal 100-
gram carbohydrate diet and a 1400 kcal 75-gram carbohydrate diet.
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